Total Body Sodium Balance in Chronic Kidney Disease

Martin, Kylie; Tan, Sven-Jean; Toussaint, Nigel D.

doi:https://doi.org/10.1155/2021/7562357

International Journal of Nephrology

On this page

Abstract Introduction Conclusion Conflicts of Interest Acknowledgments References Copyright Related Articles

Review Article | Open Access

Volume 2021 | Article ID 7562357 | https://doi.org/10.1155/2021/7562357

Total Body Sodium Balance in Chronic Kidney Disease

Kylie Martin,^1,2Sven-Jean Tan,^1,2and Nigel D. Toussaint^1,2

Academic Editor: Joshua Rein

Received05 May 2021

Revised09 Aug 2021

Accepted13 Sept 2021

Published22 Sept 2021

Abstract

Excess sodium intake is a leading but modifiable risk factor for mortality, with implications on hypertension, inflammation, cardiovascular disease, and chronic kidney disease (CKD). This review will focus mainly on the limitations of current measurement methods of sodium balance particularly in patients with CKD who have complex sodium physiology. The suboptimal accuracy of sodium intake and excretion measurement is seemingly more marked with the evolving understanding of tissue (skin and muscle) sodium. Tissue sodium represents an extrarenal influence on sodium homeostasis with demonstrated clinical associations of hypertension and inflammation. Measurement of tissue sodium has been largely unexplored in patients with CKD. Development and adoption of more comprehensive and dynamic assessment of body sodium balance is needed to better understand sodium physiology in the human body and explore therapeutic strategies to improve the clinical outcomes in the CKD population.

1. Introduction

Excess sodium is associated with increased mortality in patients with chronic kidney disease (CKD). As sodium excretion progressively decreases with decline in kidney function, individuals with CKD are particularly sensitive to excess sodium in tissues. This review explores current challenges in accurately evaluating sodium intake and excretion in the CKD population. We advocate for a more comprehensive and dynamic assessment of total body sodium balance, particularly with the shift in body sodium paradigm to include an appreciation of tissue (skin and muscle) sodium [1]. Innovative methods are needed to measure tissue sodium in addition to the extracellular component of osmotically active sodium that is conventionally reflected in sodium intake and excretion measurements.

2. Main Text

2.1. Evolution of Sodium’s Place at the Table

Sodium is an essential nutrient for humans, but the human body only requires small amounts [2]. Humans have evolved from an environment with little additive sodium and adapted to retain salt naturally occurring in food and water [3]. Salt has been used in food preservation and become an increasing addition to food with the advent of agriculture; but the human body has yet to adapt to excreting larger quantities of sodium [3]. High sodium intake is the leading dietary risk factor for mortality in the general population [4]. Most countries exceed the World Health Organization’s recommended daily intake of <2 grams of dietary sodium (equivalent to 5 grams of salt, sodium chloride) per day for adults [5]. Processed foods, restaurant foods, and discretionary salt and sauce intake contribute considerably [6].

Furthermore, limiting sodium intake in those with CKD is paramount as the kidney has decreased capacity to excrete sodium and water. Current Kidney Disease Improving Global Outcomes (KDIGO) guidelines also recommend limiting daily sodium intake to <2 grams for individuals with CKD [7]. As the ability to excrete sodium decreases with progressive kidney decline [8], the negative impact of sodium on health outcomes is accentuated, with higher sodium intake linked to CKD progression [9], worsening hypertension, cardiovascular mortality and morbidity [10], increasing risk of left ventricular hypertrophy [11], and vascular stiffness [12]. Sodium has also been reported to influence uraemia-related risk factors via oxidative stress pathways leading to inflammation, endothelial cell injury, and proteinuria [13, 14]. As CKD prevalence continues to rise globally [15], improving the management of sodium balance is important to address the increased cardiac mortality and morbidity. This begins with more accurate measurement of sodium intake, excretion, and removal.

2.2. Sodium Physiology and Pathophysiology in CKD

To better understand the current measurements of sodium, their strengths and limitations, and the utility in the population with CKD, one first requires a model of sodium homeostasis and physiology and the impact of CKD on this. Renal regulation of sodium, through a complex interaction of mediators involving the sympathetic nervous system, renin-angiotensin-aldosterone system, and natriuretic peptides, is required to maintain sodium homeostasis in healthy physiological states [16]. This tightly controlled system is disrupted with decreasing glomerular filtration rate and progression of CKD that increasingly compromises the kidneys’ concentrating capacity [17]. With an overall decrease in functioning nephron mass, there is a compensatory increase in the fractional sodium load excretion per nephron unit with the consequent insult of increased osmotic diuresis [17]. Volume-dependent and independent factors influencing atrial natriuretic peptide increase the renal blood flow and decrease sodium reabsorption in the distal tubules [18, 19]. With the progression of renal decline, these adaptive mechanisms are overridden leading to a net salt excess, hypertension, and clinically evident fluid overload [17]. However, some observational studies have demonstrated that high sodium intake or positive sodium balance does not correlate with a concomitant increase in extracellular volume, total body weight, or rise in serum sodium in healthy individuals [20, 21]. This has been explained by a greater appreciation of extrarenal sodium handling in tissues (skin and muscle) over the last two decades [1]. This further complicates the understanding of human sodium physiology in those with CKD.

How sodium is stored and regulated in tissues is not entirely clear and requires further investigation. In some studies of rodent and human tissues, sodium has been demonstrated to be bound to the glycosaminoglycan- (GAG-) rich tissue interstitium in a water-independent manner [22, 23]. The electrostatic interaction between negatively charged GAG and sodium inactivates the osmotic effects of excess sodium and prevents the extracellular fluid expansion [23]. Dermal sodium is correlated with increasing GAG content in the skin [24]. In a hypertonic microenvironment, skin phagocytes activate tonicity enhancer binding proteins and vascular endothelial growth factors (VEGF-C) mediating lymphangiogenesis. This modulates cutaneous lymph capillary density and induces local tissue electrolyte clearance to regulate skin sodium levels [25]. This water-free storage of tissue sodium has been consolidated by ¹H and ²³Na MRI images that can colocate sodium and water in Kopp et al.’s work, which demonstrated an age-dependent increase in male muscle content without an associated increase in serum sodium or water content and volume expansion [24]. Additionally, the role of epithelial sodium channel (ENaC) in endothelial, vascular smooth muscle, and immune cells, like monocytes, that mobilise in and out of tissues has also been an area of interest involved in extrarenal blood pressure regulation [26]. Hydration levels through mediation by ENaC can influence dermal fibroblasts and skin inflammatory responses [27]. Skin provides an environment for cellular crosstalk, similar to the kidney. Endothelial cells can act as vascular salt sensors and modulate the mechanical stiffness of the cell plasma membrane by also activating ENaC and nitric oxide release in response to sodium concentrations in plasma [28]. However, others have posited that the increased tissue sodium signal is related to a shift of sodium intracellularly in exchange for potassium [29] or a systemic change in the extracellular to intracellular compartments with isotonic sodium accumulation in the extracellular space with concomitant water [30]. Therefore, more studies need to be conducted into the physiology of tissue sodium to better understand how this compartment relates to the totality of human sodium balance.

2.3. Current Urinary Measurement Methods of Sodium Balance: Strengths, Limitations, and Challenges in CKD

Current methods of measuring sodium intake rely on estimating sodium from dietary records or by excretion either with 24-hour urine collections or predictive equations from spot urinary sodium. Comprehensively collected 24-hour urine sodium (24 hUNa) is considered the gold standard for measuring dietary sodium intake [31], with various studies linking 24 hUNa to adverse outcomes in both the general population and those with CKD [32, 33]. However, 24-hour urine collections are cumbersome for patients and prone to undercollection [34]. Therefore, use of predictive equations to estimate 24 hUNa using spot urine tests have been developed as a more practical and repeatable means of measuring urinary excretion. Predictive equations to estimate 24 hUNa using spot urine tests in the non-CKD population are summarised in Table 1. Dysregulated sodium physiology in CKD complicates the accuracy of urine sodium measurement. For example, total sodium urinary output is decreased in stage 5 CKD compared with a less advanced CKD [35]. Table 2 outlines studies comparing two methods of urinary sodium measurement in patients with CKD (24 hUNa vs. predictive equations to estimate 24 hUNa using spot urine tests) published in indexed journals over the last twenty years [36–39].

2.3.1. Estimates of 24-Hour Urinary Sodium Collections from General Populations

Three studies included in Table 2 evaluated the Tanaka and/or Kawasaki predictive equations, derived from non-CKD cohorts, in CKD populations of Japan [40–42], where dietary sodium intake is relatively higher [43]. The mean estimated glomerular filtration rate (eGFR) in these four studies ranged widely from 31 to 53 mL/min/1.73 m². There was generally an equal ratio of males to females except for the study by Imai et al., which involved 72.1% males [41]. The Tanaka equation was more accurate in Japanese patients with CKD compared with the Kawasaki equation in the study by Imai et al. [41]. However, this study collected first morning urine samples, which may be more practical, whereas the Kawasaki equation utilises the second morning urine sample. Similarly, Ogura et al. reported that estimated sodium excretion using Tanaka’s method (developed from INTERSALT Japanese data) significantly correlated with measured sodium excretion in another cohort of Japanese patients with stages 1 to 5 CKD [42]. Estimated sodium excretion correlated better in those with eGFR <30 mL/min and when the sodium excretion cut-off point was >170 mEq/day. This suggests Tanaka’s estimation in a Japanese CKD population is more accurate at the lower range of kidney function and higher sodium intake. In contrast, Amano et al. reported considerable differences between 24 hUNa compared with sodium excretion estimated from untimed spot urine samples using the Tanaka formula. This study was also conducted in a CKD Japanese population but involved a higher mean eGFR of 42.8 ± 23.9 mL/min/1.73 m² [40]. Dougher et al. similarly showed that the Nerbass, INTERSALT, and Tanaka equations underestimated sodium excretion when dietary intake was high [44]. These four studies emphasise that predictive equations derived from healthy cohorts are not validated in heterogeneous CKD populations and the accuracy of these predictive equations may be affected by level of kidney function.

Furthermore, there are other factors that influence measured sodium in spot urine samples. Accuracy of urine sodium estimation seemed dependent on the collection time of the spot urine sample in those with CKD. The normal circadian pattern of electrolyte and water excretion is disrupted in patients with CKD [45]. Nighttime urinary sodium excretion can be influenced by daytime exercise [46] and dietary sodium intake [47]. Elevated nocturnal blood pressure leads to higher nighttime urinary sodium excretion [48], whereby urinary sodium excretion can be up to 30% to 40% higher in those with eGFR <60 mL/min/1.73 m² [49]. Timing of spot urine samples was inconsistent with the prescribed timing of spot urine samples in the original predictive equations (shown in Table 1) in the reviewed studies in Table 2. For example, the Kawasaki equation, designed for use with a second morning void, may have been affected by the use of an untimed spot urine sample in the study by Dougher et al. [44]. Therefore, utilising an inappropriately timed urine sample will distort the accuracy of spot urine sodium predictive equations to estimate 24 hUNa. It is also challenging to apply predictive equations using spot urine sodium samples to estimate 24 hUNa in populations that are geographically different to the sample populations from which they were derived. The Nerbass et al. [50] (developed from a stage 3 CKD population from the United Kingdom (UK)), INTERSALT [39] (developed from a healthy North American and European population), and Tanaka et al. [37] and Kawasaki et al. equations [38] (both developed from a healthy Japanese population) had poor precision and accuracy in estimating sodium excretion from untimed urine samples in patients with stages 3 and 4 CKD from the United States (US) [44]. This may be explained by differences in diet and body weight [51]. Alternatively, the use of a standardised spot urine potassium in the INTERSALT equation of this study instead of a randomly collected spot urine potassium may distort the predictive value. Decreasing kidney function, increasing age, and dietary restrictions would impact the creatinine and potassium values applied in the INTERSALT equation [52].

2.3.2. Estimates of 24-Hour Urinary Sodium Collections from CKD Populations

Estimations of 24 hUNa from spot urine sodium levels specifically developed from CKD populations may more accurately reflect the physiology of kidney dysfunction compared with those developed in non-CKD populations. In patients with CKD, it is difficult to assess the degree of accuracy to which urinary sodium excretion approximates dietary sodium intake due to the disrupted handling of sodium by the kidney. We identified five 24 hUNa predictive formulae developed in CKD populations in Table 2 [50, 53–56]. However, kidney dysfunction was not severe. Hu et al. developed the CKDSALT formula with validation in patients with stages 1 to 4 CKD [53]. The CKDSALT equation showed lowest bias with limits of agreement compared with the Kawasaki, INTERSALT, and Tanaka formulae. However, this method requires 24-hour urine volume as an equation variable, which suggests that the decreased urine volume in patients with CKD has an important effect on estimating urinary sodium in those with CKD. This study highlights the potential to strike a balance between practicality and accuracy with predictive equations by simply recording urine volume without the cumbersome need to collect the urine. Hu et al. also found utilising first morning urine in the Kawasaki equation led to overestimation in patients with CKD. Thus, the predictive accuracy of the Kawasaki equation may be affected by nocturnal natriuresis in CKD. Kang et al. showed that spot urinary sodium levels collected in the evening were 28% higher than in the morning, and the mean of three spot urinary sodium samples was better correlated with 24 hUNa measurements compared with individual spot urinary sodium results in CKD patients [57]. Kim et al. developed the ESPECIAL formula in a young Korean cohort with stages 1 to 3 CKD [54]. This formula was more reliable in predicting 24 hUNa using fasting morning urine samples compared with Kawasaki, INTERSALT, Tanaka, and Nerbass formulae in this cohort of mild-moderate kidney dysfunction. As such, this ESPECIAL formula may not be as accurate in more severe stages of CKD. Nerbass et al. developed a new formula in stage 3 CKD patients from the UK using an early morning urine. In comparison, Tanaka’s formula was only weakly correlated in the same study population [50]. Nerbass et al. also developed a new formula to estimate 24 hUNa in those with a high sodium intake (>3.6 g/day) from a second void spot urine sample of Brazilian patients with CKD [55]. These two studies by Nerbass et al. demonstrated that estimates are sensitive in high sodium consumption in the CKD population, which may be clinically useful in assessing high sodium intake in large cohort or observational studies. In contrast, Subramanian et al. developed a model for predicting 24 hUNa <100 mmol in a multiethnic Asian population with and without CKD [56]. It is inherently difficult to take into account variable ages, diuretic use, urine volume and creatinine excretion, stages of CKD, and individualised diet and fluid restrictions when developing a predictive equation to estimate 24 hUNa from spot urine sodium samples in CKD. Therefore, it is difficult to generalise these equations to a global heterogeneous CKD population with variable medications.

2.4. Nonurinary Measurements of Sodium Balance: Intake and Excretion/Removal

As can be appreciated, there is a need for innovative and practical methods of sodium measurement or monitoring. Other measurement methods to capture sodium removal, concentration, and tissue storage not using conventional urinary sodium measurements are outlined in Table 3. Urine chloride strips to self-monitor sodium intake were found to be significantly interrelated with 24 hUNa [58]. Participants in this study had predominantly stage 3 CKD, with a mean eGFR of 40.4 mL/min/1.73 m². However, other sources of dietary chloride, besides sodium chloride, can cloud the results, and the chloride strips were only sensitive at identifying patients with 24 hUNa >100 mmol/day. Although patients found this self-monitoring of high sodium intake technique useful, this method requires patients’ motivation to collect 24-hour urine volumes for self-testing, which can be cumbersome.

Patients with kidney failure on dialysis rely on a dialyser and dialysate sodium gradients (in haemodialysis) or peritoneal membrane and peritoneal fluid composition (in peritoneal dialysis) to remove sodium. A small cohort of patients on haemodialysis was assessed for sodium removal by the dialyser compared with sodium retrieval in ultrafiltrate and dialysate [59]. There was no relationship between measured sodium removal from the vascular space and tissue sodium removal and no relationship between dialysate/plasma sodium concentration gradients and tissue sodium removal. This suggests that the secondary clearance of tissue sodium is quantitatively less predictable despite successful intravascular sodium removal. Hence, we need to quantify the sodium pool in tissue in vivo.

Dietary records are another way of measuring sodium intake. However, only three published studies in the CKD population have reported sodium dietary intake in the last two decades [57, 60, 61]. Hallvass et al. compared 24 hUNa with total sodium consumption in a three-day food record (two consecutive days and one day of the weekend) in CKD patients with a mean eGFR of 38.9 ± 15.4 mL/min/1.73 m² [61]. These records were checked by a dietician with software calculation. Calculations also included discretionary sodium, which can be hard to measure. They found a comparable mean sodium consumption (4.49 ± 2.19 g/24 h) in CKD to measured 24 hUNa (4.14 ± 1.71 g/24 h). Similarly, Kim et al. found that a one-day diet diary (assessed by a dietician that included discretionary sodium) significantly correlated with 24-hour sodium removal measurements (the sum of 24 hUNa and peritoneal sodium removal) in a younger cohort of patients on peritoneal dialysis (mean age <60 years) [60]. This study was opportunistic and minimally burdensome to patients who routinely collected urine volumes for dialysis adequacy assessment. Notably, dietetic resources may be more readily available in clinical studies. Kang et al. also found that mean spot urinary sodium tended to be better correlated with 24 hUNa compared with sodium intake recorded on dietary recall [57]. Sodium intake estimates based on food diaries, food-frequency questionnaires, and 24-hour or multiday recall are relatively easy to conduct. However, they tend to underestimate sodium intake compared with estimates obtained from duplicate diets and 24-hour urine collections [62]. Sodium intake estimates are inherently susceptible to recall and reporting bias and are interviewer-dependent [63, 64].

2.5. Limitations of Current Sodium Balance Measurements

The heterogeneity in the studies in Tables 2 and 3 highlights the limitations of current measurements including inaccuracies and challenges in clinical practice. Although it is of low cost, 24 hUNa comes with inherent challenges of high participant burden and susceptibility to inaccurate collection in clinical practice. Completeness of 24 hUNa collection was unclear in some of the studies included in this review. Varied provision of verbal and/or written collection instructions potentially affects urine collection completeness [65]. Up to half of 24-hour urine collections are undercollected [34], and only three studies assessed urine collection adequacy with creatinine clearance criteria [42, 50, 57]. Attempts to capture interday variation with repeat 24-hour measurements in patients with stages 3 and 4 CKD at regular intervals have been compared with single 24 hUNa measurements with some success [44]. However, 24-hour urinary creatinine excretion also demonstrates intradaily variation affected by protein intake, exercise, and muscle mass [66, 67]. Measurement of urinary creatinine excretion in CKD is further complicated by considerable muscle mass wasting and low glomerular filtration [68]. With these limitations, it is difficult to define a gold standard to measure urinary sodium in CKD though there has been a reliance on 24-hour urine collections as this remains a practical option in clinical practice. Spot urine tests are less cumbersome and more practical to collect. However, accuracy varies when predictive equations are applied to CKD cohorts, depending on origin of predictive model. Shorter durations (less than 24 hours) of urine collection, which increase collection completeness and decrease participant burden, may strike a balance. Equations estimating 24 hUNa derived from 12-hour urine collections performed better than spot urines in patients with CKD [69]. A timed period of collection may negate intraday spot urine sodium excretion variation. Additionally, the aforementioned measurement methods also do not account for extrarenal losses or tissue sodium content, neglecting a clinically significant part of body sodium composition.

2.6. Evaluating Tissue Sodium Content

Visualisation of sodium tissue content by sodium-23 magnetic resonance imaging (²³Na MRI) has shown the potential of supplement measurements of sodium dietary intake and urinary sodium excretion to better reflect whole body sodium levels [1]. ²³Na MRI has been used to characterise sodium content in different body areas to understand human pathology. Currently, ²³Na MRI characterises human tissue sodium concentrations typically using a dedicated knee coil to acquire quantitative sodium images of calf tissue (skin and muscle) [70].

Studies visualising the sodium tissue signal with ²³Na MRI have demonstrated that tissue sodium is correlated with age [24, 59, 71–73] and male gender [24, 71–74] in healthy controls as well as those with CKD. In CKD, tissue sodium concentrations increase progressively across the spectrum [74]. Patients with kidney failure on haemodialysis and peritoneal dialysis have significantly higher sodium concentrations in the skin, soleus, and tibia compared with controls [74]. Sodium quantification by ²³Na MRI demonstrated that patients with refractory hypertension had significantly increased sodium content compared with normal controls, when controlled for age [24]. In patients with primary hyperaldosteronism, surgical or medical treatment with spironolactone for hypertension decreased muscle sodium content by 30% (26.1 ± 3.1 vs. 18.3 ± 2.7 mmol/L) with no effect on body weight, demonstrating that tissue sodium content is mobilizable [72].

As tissue sodium storage has been demonstrated to be exchangeable, it could be said that intraindividual tissue sodium could change across time, but further studies are required to explore this. There has yet to be studies of serial ²³Na MRI in individuals without interventions to ascertain an understanding of the natural physiological variations in tissue sodium content. Other studies have explored the effect of haemodialysis [54, 59] and altering haemodialysis dialysate sodium concentration [75] on tissue sodium content, but other confounding factors that can influence tissue sodium content need exploration across the spectrum of CKD and dialysis modalities. Such studies could have important implications for novel therapeutic targets to reduce total body sodium content and improve clinical outcomes.

Clinical associations of tissue sodium content are in the early stages of being elucidated in small studies. Tissue sodium is associated with inflammation, immune dysregulation, and hypertension, independent of circulating osmotically active sodium [24]. Skin sodium concentration correlates with left ventricular mass, independent of blood pressure and overhydration [71]. Studies have also yet to delineate the implications of tissue sodium on clinical outcomes, like cardiovascular mortality independent of osmotically active sodium in the extracellular space. Overall, these human studies evaluating tissue sodium concentration using ²³Na MRI do not have any controlled dietary interventions and have not correlated findings with sodium dietary intake measurements or urinary sodium excretion (routinely available methods in current clinical practice).

A detailed clinical cost analysis and efficacy study would be required if indeed MRI will provide additional data in the overall assessment and management of a patient in the clinical setting. Although requiring technical expertise, time, and higher costs than current sodium intake measurements, ²³Na MRI is an emerging clinical tool that has the potential to supplement current sodium measurements in clinical studies to better understand body sodium balance. Given salt’s dramatic negative consequences on health outcomes, it would be vital to explore the clinical associations of tissue sodium and novel therapeutic targets.

3. Conclusion

Current measurements of sodium urinary excretion and dietary intake do not reflect the total body sodium balance. Twenty-four-hour urine collections are considered more accurate than spot urine sodium measurements but are also onerous for patients. Equations to estimate 24 hUNa from spot urine sodium samples developed from healthy populations are not reliable in heterogeneous CKD patients. Predictive equations developed specifically in CKD cohorts require further validation in different CKD stages and ethnic and geographical groups. These predictive formulae are also not applicable for individual sodium assessment as they were developed in larger scale cohort and epidemiological studies. Dietary records are inherently prone to recall bias and not reflective of interday variation.

Comprehensive and physiologically accurate measurements of sodium balance need to include tissue sodium levels. The advent of ²³Na MRI adds further weight to extrarenal sodium handling. However, more studies are needed to compare tissue sodium concentrations with current measurements of sodium intake and sodium urinary excretion. Future larger prospective studies can evaluate the sodium reduction strategies and associated clinical outcomes using ²³Na MRI that measure changes in tissue sodium content. We need to better understand and ameliorate the negative clinical impacts of tissue sodium, especially in patients with CKD, as there have been little interventional advances in this space in recent times. Utilising novel imaging technology may help pave the way.

Conflicts of Interest

The authors have no conflicts of interest to declare.

Acknowledgments

This work was supported by the Australian Commonwealth Government and University of Melbourne Research Training Program.

References

B. Canaud, J. Kooman, N. M. Selby et al., “Sodium and water handling during hemodialysis: new pathophysiologic insights and management approaches for improving outcomes in end-stage kidney disease,” Kidney International, vol. 95, no. 2, pp. 296–309, 2019.
View at: Publisher Site | Google Scholar
L. K. Dahl, “Salt and hypertension,” American Journal of Clinical Nutrition, vol. 25, no. 2, pp. 231–244, 1972.
View at: Publisher Site | Google Scholar
F. L. Jackson, “An evolutionary perspective on salt, hypertension, and human genetic variability,” Hypertension, vol. 17, no. 1S, pp. I129–I132, 1991.
View at: Publisher Site | Google Scholar
GBD 2017 Risk Factor Collaborators, “Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017,” Lancet, vol. 392, no. 10159, pp. 1923–1994, 2018.
View at: Google Scholar
D. Mozaffarian, S. Fahimi, G. M. Singh et al., “Global sodium consumption and death from cardiovascular causes,” New England Journal of Medicine, vol. 371, no. 7, pp. 624–634, 2014.
View at: Publisher Site | Google Scholar
W. P. James, A. Ralph, and C. Sanchez-Castillo, “The dominance of salt in manufactured food in the sodium intake of affluent societies,” The Lancet, vol. 329, no. 8530, pp. 426–429, 1987.
View at: Publisher Site | Google Scholar
Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group, “KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease,” Kidney International, vol. 99, no. 3S, pp. S1–S87, 2021.
View at: Publisher Site | Google Scholar
D. Shemin and L. D. Dworkin, “Sodium balance in renal failure,” Current Opinion in Nephrology and Hypertension, vol. 6, no. 2, pp. 128–132, 1997.
View at: Publisher Site | Google Scholar
M. Kang, E. Kang, H. Ryu et al., “Measured sodium excretion is associated with CKD progression: results from the KNOW-CKD study,” Nephrology Dialysis Transplantation, vol. 36, no. 3, pp. 512–519, 2021.
View at: Publisher Site | Google Scholar
F. J. He, M. Tan, Y. Ma, and G. A. MacGregor, “Salt reduction to prevent hypertension and cardiovascular disease,” Journal of the American College of Cardiology, vol. 75, no. 6, pp. 632–647, 2020.
View at: Publisher Site | Google Scholar
F. H. Messerli, R. E. Schmieder, and M. R. Weir, “Salt,” Archives of Internal Medicine, vol. 157, no. 21, pp. 2449–2452, 1997.
View at: Publisher Site | Google Scholar
G. du Cailar, A. Mimran, P. Fesler, J. Ribstein, J. Blacher, and M. E. Safar, “Dietary sodium and pulse pressure in normotensive and essential hypertensive subjects,” Journal of Hypertension, vol. 22, no. 4, pp. 697–703, 2004.
View at: Publisher Site | Google Scholar
E. Ritz, R. Dikow, C. Morath, and V. Schwenger, “Salt—a potential “uremic toxin”?” Blood Purification, vol. 24, no. 1, pp. 63–66, 2006.
View at: Publisher Site | Google Scholar
M. J. E. Dekker, B. Canaud, D. Marcelli et al., “Unraveling the relationship between mortality, hyponatremia, inflammation and malnutrition in hemodialysis patients: results from the international MONDO initiative,” European Journal of Clinical Nutrition, vol. 70, no. 7, pp. 779–784, 2016.
View at: Publisher Site | Google Scholar
N. R. Hill, S. T. Fatoba, J. L. Oke et al., “Global prevalence of chronic kidney disease—a systematic review and meta-analysis,” PLoS One, vol. 11, no. 7, Article ID e0158765, 2016.
View at: Publisher Site | Google Scholar
V. Soi and J. Yee, “Sodium homeostasis in chronic kidney disease,” Advances in Chronic Kidney Disease, vol. 24, no. 5, pp. 325–331, 2017.
View at: Publisher Site | Google Scholar
S. Combs and T. Berl, “Dysnatremias in patients with kidney disease,” American Journal of Kidney Diseases, vol. 63, no. 2, pp. 294–303, 2014.
View at: Publisher Site | Google Scholar
N. L. M. Wong, J. K. H. Luk, and E. F. C. Wong, “In vitro hormone-stimulated atrial natriuretic factor release is increased in experimental renal failure,” Nephron, vol. 69, no. 1, pp. 59–64, 1995.
View at: Publisher Site | Google Scholar
J. K. Luk, E. F. Wong, and N. L. Wong, “Downregulation of atrial natriuretic factor clearance receptors in experimental chronic renal failure rats,” American Journal of Physiology, vol. 269, no. 3 Pt 2, pp. H902–H908, 1995.
View at: Publisher Site | Google Scholar
R. H. G. Olde Engberink, N. M. G. Rorije, B.-J. H. van den Born, and L. Vogt, “Quantification of nonosmotic sodium storage capacity following acute hypertonic saline infusion in healthy individuals,” Kidney International, vol. 91, no. 3, pp. 738–745, 2017.
View at: Publisher Site | Google Scholar
N. Rakova, K. Jüttner, A. Dahlmann et al., “Long-term space flight simulation reveals infradian rhythmicity in human Na⁺ balance,” Cell Metabolism, vol. 17, no. 1, pp. 125–131, 2013.
View at: Publisher Site | Google Scholar
J. Titze, M. Shakibaei, M. Schafflhuber et al., “Glycosaminoglycan polymerization may enable osmotically inactive Na⁺ storage in the skin,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 287, no. 1, pp. H203–H208, 2004.
View at: Publisher Site | Google Scholar
M. Fischereder, B. Michalke, E. Schmöckel et al., “Sodium storage in human tissues is mediated by glycosaminoglycan expression,” American Journal of Physiology—Renal Physiology, vol. 313, no. 2, pp. F319–F325, 2017.
View at: Publisher Site | Google Scholar
C. Kopp, P. Linz, A. Dahlmann et al., “23 Na magnetic resonance imaging-determined tissue sodium in healthy subjects and hypertensive patients,” Hypertension, vol. 61, no. 3, pp. 635–640, 2013.
View at: Publisher Site | Google Scholar
A. Machnik, W. Neuhofer, J. Jantsch et al., “Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism,” Nature Medicine, vol. 15, no. 5, pp. 545–552, 2009.
View at: Publisher Site | Google Scholar
A. L. PitzerJ. P. Van Beusecum, J. P. Van Beusecum, T. R. Kleyman, and A. Kirabo, “ENaC in salt-sensitive hypertension: kidney and beyond,” Current Hypertension Reports, vol. 22, no. 9, p. 69, 2020.
View at: Publisher Site | Google Scholar
W. Xu, S. J. Hong, M. Zeitchek et al., “Hydration status regulates sodium flux and inflammatory pathways through epithelial sodium channel (ENaC) in the skin,” Journal of Investigative Dermatology, vol. 135, no. 3, pp. 796–806, 2015.
View at: Publisher Site | Google Scholar
H. Oberleithner, K. Kusche-Vihrog, and H. Schillers, “Endothelial cells as vascular salt sensors,” Kidney International, vol. 77, no. 6, pp. 490–494, 2010.
View at: Publisher Site | Google Scholar
G. Bhave and E. G. Neilson, “Body fluid dynamics: back to the future,” Journal of the American Society of Nephrology, vol. 22, no. 12, pp. 2166–2181, 2011.
View at: Publisher Site | Google Scholar
G. Rossitto, S. Mary, J. Y. Chen et al., “Tissue sodium excess is not hypertonic and reflects extracellular volume expansion,” Nature Communications, vol. 11, no. 1, p. 4222, 2020.
View at: Publisher Site | Google Scholar
Pan American Health Organization, WHO/PAHO Regional Expert Group for Cardiovascular Disease Prevention through Population-Wide Dietary Salt Reduction: Protocol for Population Level Sodium Determination in 24-Hour Urine Samples, Pan American Health Organization, Washington, DC, USA, 2010, https://www.paho.org/hq/dmdocuments/2013/24-h-urine-Protocol-eng.pdf.
A. Mente, M. O’Donnell, S. Rangarajan et al., “Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies,” The Lancet, vol. 388, no. 10043, pp. 465–475, 2016.
View at: Publisher Site | Google Scholar
K. T. Mills, J. Chen, W. Yang et al., “Sodium excretion and the risk of cardiovascular disease in patients with chronic kidney disease,” Journal of the American Medical Association, vol. 315, no. 20, pp. 2200–2210, 2016.
View at: Publisher Site | Google Scholar
K. A. John, M. E. Cogswell, N. R. Campbell et al., “Accuracy and usefulness of select methods for assessing complete collection of 24‐hour urine: a systematic review,” Journal of Clinical Hypertension, vol. 18, no. 5, pp. 456–467, 2016.
View at: Publisher Site | Google Scholar
A. Aybal Kutlugün, M. Arıcı, T. Yıldırım et al., “Daily sodium intake in chronic kidney disease patients during nephrology clinic follow-up: an observational study with 24-hour urine sodium measurement,” Nephron Clinical Practice, vol. 118, no. 4, pp. c361–c366, 2011.
View at: Publisher Site | Google Scholar
K. Kamata and O. Tochikubo, “Estimation of 24 h urinary sodium excretion using lean body mass and overnight urine collected by a pipe-sampling method,” Journal of Hypertension, vol. 20, no. 11, pp. 2191–2197, 2002.
View at: Publisher Site | Google Scholar
T. Tanaka, T. Okamura, K. Miura et al., “A simple method to estimate populational 24 h urinary sodium and potassium excretion using a casual urine specimen,” Journal of Human Hypertension, vol. 16, no. 2, pp. 97–103, 2002.
View at: Publisher Site | Google Scholar
T. Kawasaki, K. Itoh, K. Uezono, and H. Sasaki, “A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults,” Clinical and Experimental Pharmacology and Physiology, vol. 20, no. 1, pp. 7–14, 1993.
View at: Publisher Site | Google Scholar
I. J. Brown, A. R. Dyer, Q. Chan et al., “Estimating 24-hour urinary sodium excretion from casual urinary sodium concentrations in western populations,” American Journal of Epidemiology, vol. 177, no. 11, pp. 1180–1192, 2013.
View at: Publisher Site | Google Scholar
H. Amano, S. Kobayashi, H. Terawaki, M. Ogura, Y. Kawaguchi, and T. Yokoo, “Measurement of daily sodium excretion in patients with chronic kidney disease; special reference to the difference between the amount measured from 24 h collected urine sample and the estimated amount from a spot urine,” Renal Failure, vol. 40, no. 1, pp. 238–242, 2018.
View at: Publisher Site | Google Scholar
E. Imai, Y. Yasuda, M. Horio et al., “Validation of the equations for estimating daily sodium excretion from spot urine in patients with chronic kidney disease,” Clinical and Experimental Nephrology, vol. 15, no. 6, pp. 861–867, 2011.
View at: Publisher Site | Google Scholar
M. Ogura, A. Kimura, K. Takane et al., “Estimation of salt intake from spot urine samples in patients with chronic kidney disease,” BMC Nephrology, vol. 13, no. 1, p. 36, 2012.
View at: Publisher Site | Google Scholar
K. Uechi, K. Asakura, S. Masayasu, and S. Sasaki, “Within-country variation of salt intake assessed via urinary excretion in Japan: a multilevel analysis in all 47 prefectures,” Hypertension Research, vol. 40, no. 6, pp. 598–605, 2017.
View at: Publisher Site | Google Scholar
C. E. Dougher, D. E. Rifkin, C. A. Anderson et al., “Spot urine sodium measurements do not accurately estimate dietary sodium intake in chronic kidney disease,” American Journal of Clinical Nutrition, vol. 104, no. 2, pp. 298–305, 2016.
View at: Publisher Site | Google Scholar
L. Centonza, G. Castoldi, R. Chianca et al., “Short-term analysis of the relationship between blood pressure and urinary sodium excretion in normotensive subjects,” Clinical Science, vol. 98, no. 4, pp. 495–500, 2000.
View at: Publisher Site | Google Scholar
J. B. Dossetor, H. M. Gorman, and J. C. Beck, “The diurnal rhythm of urinary electrolyte excretion: I. observations in normal subjects,” Metabolism: Clinical and Experimental, vol. 12, pp. 1083–1099, 1963.
View at: Google Scholar
H. Pollack, “Creatinine excretion as index for estimating urinary excretion of micronutrients or their metabolic end products,” American Journal of Clinical Nutrition, vol. 23, no. 7, pp. 865–867, 1970.
View at: Publisher Site | Google Scholar
M. Fukuda, M. Motokawa, S. Miyagi et al., “Polynocturia in chronic kidney disease is related to natriuresis rather than to water diuresis,” Nephrology Dialysis Transplantation, vol. 21, no. 8, pp. 2172–2177, 2006.
View at: Publisher Site | Google Scholar
R. Agarwal, “Relationship between circadian blood pressure variation and circadian protein excretion in chronic kidney disease,” American Journal of Physiology—Renal Physiology, vol. 293, pp. F655–F659, 2007.
View at: Google Scholar
F. B. Nerbass, R. Pecoits-Filho, N. J. McIntyre, C. W. McIntyre, and M. W. Taal, “Development of a formula for estimation of sodium intake from spot urine in people with chronic kidney disease,” Nephron Clinical Practice, vol. 128, no. 1-2, pp. 61–66, 2014.
View at: Publisher Site | Google Scholar
C. Ji, M. A. Miller, A. Venezia, P. Strazzullo, and F. P. Cappuccio, “Comparisons of spot vs 24 h urine samples for estimating population salt intake: validation study in two independent samples of adults in Britain and Italy,” Nutrition, Metabolism, and Cardiovascular Diseases, vol. 24, no. 2, pp. 140–147, 2014.
View at: Publisher Site | Google Scholar
S. I. Hallan, K. Dahl, C. M. Oien et al., “Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey,” BMJ, vol. 333, no. 7577, p. 1047, 2006.
View at: Publisher Site | Google Scholar
J. Hu, Y. Wang, N. Song et al., “Estimating 24-hour urinary sodium excretion from spot urine samples in chronic kidney disease patients,” Journal of Renal Nutrition, vol. 30, no. 1, pp. 11–21, 2020.
View at: Publisher Site | Google Scholar
S.-Y. Kim, Y. H. Lee, Y.-G. Kim et al., “Estimating the urinary sodium excretion in patients with chronic kidney disease is not useful in monitoring the effects of a low-salt diet,” Kidney Research and Clinical Practice, vol. 37, no. 4, pp. 373–383, 2018.
View at: Publisher Site | Google Scholar
F. B. Nerbass, A. E. Hallvass, M. W. Taal, and R. Pecoits-Filho, “Formula to detect high sodium excretion from spot urine in chronic kidney disease patients,” Jornal Brasileiro De Nefrologia, vol. 39, no. 1, pp. 23–28, 2017.
View at: Publisher Site | Google Scholar
S. Subramanian, B. W. Teo, Q. C. Toh et al., “Spot urine tests in predicting 24-hour urine sodium excretion in Asian patients,” Journal of Renal Nutrition, vol. 23, no. 6, pp. 450–455, 2013.
View at: Publisher Site | Google Scholar
S. S. Kang, E. H. Kang, S. O. Kim, M. S. Lee, C. D. Hong, and S. B. Kim, “Use of mean spot urine sodium concentrations to estimate daily sodium intake in patients with chronic kidney disease,” Nutrition, vol. 28, no. 3, pp. 256–261, 2012.
View at: Publisher Site | Google Scholar
V. Panuccio, P. Pizzini, G. Parlongo et al., “Urine chloride self-measurement to monitor sodium chloride intake in patients with chronic kidney disease,” Clinical Chemistry and Laboratory Medicine, vol. 57, no. 8, pp. 1162–1168, 2019.
View at: Publisher Site | Google Scholar
A. Dahlmann, K. Dörfelt, F. Eicher et al., “Magnetic resonance-determined sodium removal from tissue stores in hemodialysis patients,” Kidney International, vol. 87, no. 2, pp. 434–441, 2015.
View at: Publisher Site | Google Scholar
S. M. Kim, E. K. Lee, S. S. Kang, S. M. Kim, H. W. Kim, and S. B. Kim, “Simple method to estimate daily sodium intake during measurement of dialysis adequacy in chronic peritoneal dialysis patients,” Asia Pacific Journal of Clinical Nutrition, vol. 26, no. 6, pp. 1001–1006, 2017.
View at: Google Scholar
A. E. C. Hallvass, L. M. Claro, S. Gonçalves et al., “Evaluation of salt intake, urinary sodium excretion and their relationship to overhydration in chronic kidney disease patients,” Blood Purification, vol. 40, no. 1, pp. 59–65, 2015.
View at: Publisher Site | Google Scholar
R. M. McLean, V. L. Farmer, A. Nettleton et al., “Twenty-four-hour diet recall and diet records compared with 24-hour urinary excretion to predict an individual’s sodium consumption: a systematic review,” Journal of Clinical Hypertension, vol. 20, no. 10, pp. 1360–1376, 2018.
View at: Publisher Site | Google Scholar
M. Jain, G. R. Howe, and T. Rohan, “Dietary assessment in epidemiology: comparison of a food frequency and a diet history questionnaire with a 7-day food record,” American Journal of Epidemiology, vol. 143, no. 9, pp. 953–960, 1996.
View at: Publisher Site | Google Scholar
S. A. Bingham, “Limitations of the various methods for collecting dietary intake data,” Annals of Nutrition & Metabolism, vol. 35, pp. 117–127, 1991.
View at: Publisher Site | Google Scholar
M. Miler and A.-M. Šimundić, “Low level of adherence to instructions for 24-hour urine collection among hospital outpatients,” Biochemia Medica, vol. 23, no. 3, pp. 316–320, 2013.
View at: Publisher Site | Google Scholar
J. Calles-Escandon, J. J. Cunningham, P. Snyder et al., “Influence of exercise on urea, creatinine, and 3-methylhistidine excretion in normal human subjects,” American Journal of Physiology, vol. 246, no. 4 Pt 1, pp. E334–E338, 1984.
View at: Publisher Site | Google Scholar
M. Mayersohn, K. Conrad, and R. Achari, “The influence of a cooked meat meal on creatinine plasma concentration and creatinine clearance,” British Journal of Clinical Pharmacology, vol. 15, no. 2, pp. 227–230, 1983.
View at: Publisher Site | Google Scholar
Y. Zhou, M. Hellberg, P. Svensson, P. Höglund, and N. Clyne, “Sarcopenia and relationships between muscle mass, measured glomerular filtration rate and physical function in patients with chronic kidney disease stages 3–5,” Nephrology Dialysis Transplantation, vol. 33, no. 2, pp. 342–348, 2018.
View at: Publisher Site | Google Scholar
B. De Vico Ribeiro, F. Baggio Nerbass, A. E. Chaud Hallvass, R. Pecoits-Filho, and L. Cuppari, “Development and validation of equations to estimate 24 h urinary sodium excretion from urine samples of patients with chronic kidney disease,” Nephron, vol. 143, no. 4, pp. 255–263, 2019.
View at: Google Scholar
N. K. Bangerter, J. D. Kaggie, M. D. Taylor, and J. R. Hadley, “Sodium MRI radiofrequency coils for body imaging,” NMR in Biomedicine, vol. 29, no. 2, pp. 107–118, 2016.
View at: Publisher Site | Google Scholar
M. P. Schneider, U. Raff, C. Kopp et al., “Skin sodium concentration correlates with left ventricular hypertrophy in CKD,” Journal of the American Society of Nephrology, vol. 28, no. 6, pp. 1867–1876, 2017.
View at: Publisher Site | Google Scholar
C. Kopp, P. Linz, L. Wachsmuth et al., “23 Na magnetic resonance imaging of tissue sodium,” Hypertension, vol. 59, no. 1, pp. 167–172, 2012.
View at: Publisher Site | Google Scholar
M. Sahinoz, S. Tintara, S. M. Deger et al., “Tissue sodium stores in peritoneal dialysis and hemodialysis patients determined by 23-sodium magnetic resonance imaging,” Nephrology Dialysis Transplantation, vol. 36, no. 7, pp. 1307–1317, 2020.
View at: Publisher Site | Google Scholar
E. Qirjazi, F. R. Salerno, A. Akbari et al., “Tissue sodium concentrations in chronic kidney disease and dialysis patients by lower leg sodium-23 magnetic resonance imaging,” Nephrology Dialysis Transplantation, vol. 36, no. 7, Article ID gfaa036, pp. 1234–43, 2020.
View at: Publisher Site | Google Scholar
S. Lemoine, F. R. Salerno, A. Akbari, and C. W. McIntyre, “Influence of dialysate sodium prescription on skin and muscle sodium concentration,” American Journal of Kidney Diseases, vol. 78, no. 1, pp. 156–159, 2021.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2021 Kylie Martin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

897

Downloads

969

Citations